Gujarat Terce Laboratories logo

Gujarat Terce Laboratories

GUJARATTERCELABORATORIESLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹32.76 Cr
Volatility
Moderate
P/E Ratio
15.3
EBITDA
₹4.10 Cr
Return on Equity
22.63%
Debt to Equity
0.13
Book Value
₹12.49
EPS
₹0
52W High
₹59.78
52W Low
₹29

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

1
  • Company has a low return on equity of 7.77% over last 3 years.

Growth Rate

Revenue Growth
-5.35% lower than 3Y
Net Income Growth
-320% lower than 3Y
Cash Flow Change
-44.12% lower than 3Y
ROE
-250% lower than 3Y
ROCE
-36.82% lower than 3Y
EBITDA Margin (Avg.)
3.01% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
10.72
12.03
13.02
12.21
11.89
13.3
12.68
12.32
10.85
12.93
12.29
11.4
9
Expenses
11.85
11.48
12.18
11.2
11.81
11.64
11.6
11.27
10.86
11.03
11.16
10.66
9.49
Operating Profit
-1.13
0.55
0.84
1.01
0.08
1.66
1.08
1.05
-0.01
1.9
1.13
0.74
-0.49
OPM %
-10.54%
4.57%
6.45%
8.27%
0.67%
12.48%
8.52%
8.52%
-0.09%
14.69%
9.19%
6.49%
-5.44%
Other Income
0.08
0.08
0.08
0.08
0.07
0.08
0.07
0.09
0.09
0.05
0.13
-0.37
0.48
Interest
0.17
0.2
0.16
0.15
0.13
0.13
0.08
0.07
0.05
0.07
0.04
0.03
0.03
Depreciation
0.09
0.09
0.09
0.09
0.09
0.09
0.1
0.1
0.1
0.1
0.1
0.13
0.11
PBT
-1.31
0.34
0.67
0.85
-0.07
1.52
0.97
0.97
-0.07
1.78
1.12
0.21
-0.15
Tax %
0%
0%
0%
35.29%
14.29%
1.97%
-3.09%
449.48%
-42.86%
21.35%
33.04%
47.62%
20%
Net Profit
-1.31
0.33
0.67
0.54
-0.08
1.48
1.01
-3.39
-0.04
1.4
0.76
0.1
-0.18
EPS in Rs
-1.77
0.44
0.9
0.73
-0.11
1.99
1.36
-4.57
-0.05
1.89
0.98
0.13
-0.23
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
26.48
25
25.29
29.01
31.03
37.54
25.18
40.13
46.78
47.92
50.2
47.47
45.62
Expenses
25.7
24.84
25.21
28.68
30.54
36.86
27.77
39.02
48.94
46.65
46.31
43.71
42.34
Operating Profit
0.78
0.16
0.08
0.33
0.49
0.68
-2.59
1.11
-2.16
1.27
3.89
3.76
3.28
OPM %
2.95%
0.64%
0.32%
1.14%
1.58%
1.81%
-10.29%
2.77%
-4.62%
2.65%
7.75%
7.92%
7.19%
Other Income
0.08
0.19
0.44
0.41
0.32
0.29
0.62
0.31
0.35
0.32
0.31
-0.12
0.29
Interest
0.41
0.38
0.31
0.23
0.25
0.29
0.39
0.4
0.72
0.68
0.42
0.18
0.17
Depreciation
0.16
0.19
0.19
0.19
0.21
0.24
0.18
0.28
0.36
0.37
0.38
0.42
0.44
PBT
0.29
-0.22
0.02
0.32
0.35
0.44
-2.54
0.74
-2.89
0.54
3.4
3.04
2.96
Tax %
72.41%
209.09%
150%
15.62%
-25.71%
36.36%
-0.39%
-17.57%
-42.21%
55.56%
128.53%
27.3%
—
Net Profit
0.09
-0.67
-0.01
0.27
0.43
0.28
-2.52
0.87
-1.67
0.24
-0.98
2.2
2.08
EPS in Rs
0.12
-0.9
-0.01
0.36
0.58
0.38
-3.4
1.17
-2.25
0.32
-1.32
2.82
2.77
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
7.42
7.42
7.42
7.42
7.42
7.42
7.42
7.42
7.42
7.42
7.42
7.79
Reserves
3.61
2.94
2.64
2.98
3.41
3.69
0.24
1.11
-0.56
-0.31
-0.94
1.94
Borrowings
8.21
7.13
7
0.37
0.68
2.6
4.74
6.67
7.27
3.87
0.94
1.3
Other Liabilities
7.06
6.98
6.59
8.69
7.94
8.8
9.47
12.19
14.39
12.29
15.41
13.52
Total Liabilities
26.3
24.47
23.65
19.46
19.45
22.51
21.87
27.39
28.52
23.27
22.83
24.55
Fixed Assets
6.48
6.34
6.17
1.88
2.06
2.29
2.45
4.29
3.99
3.69
3.65
3.25
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0.3
0.3
0.24
0.27
0.29
0.27
0.27
0.27
0.27
0.27
0.52
1.35
Other Assets
19.52
17.83
17.24
17.31
17.1
19.95
19.15
22.83
24.26
19.31
18.66
19.95
Total Assets
26.3
24.47
23.65
19.46
19.45
22.51
21.87
27.39
28.52
23.27
22.83
24.55
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1.38
0.16
0.24
4.58
-0.61
-1.59
-0.16
-0.44
0.03
2.6
3.06
1.71
Investing
0.08
-0.13
0.18
1.11
-0.13
-0.27
-0.42
-0.87
0.62
-0.46
0.46
-0.11
Financing
-0.73
-1.43
-0.36
-5.39
0.2
1.72
1.83
1.53
-0.12
-4.08
-2.83
0.47
Net Cash Flow
0.73
-1.39
0.06
0.29
-0.55
-0.14
1.24
0.22
0.52
-1.94
0.69
2.08
Free Cash Flow
0.92
0.1
0.23
4.45
-1.01
-2.07
-0.66
-2.55
-0.03
2.53
3.41
1.69
CFO/OP
191
406
688
1,418
-98
-219
0
-31
-3
205
81
45
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
127
124
114
57.62
53.29
68.16
74.94
49.75
62.34
43.11
36.86
37.45
Inventory Days
143
163
150
126
115
90
137
154
83.56
81.09
70.81
79.43
Days Payable
88.41
92.3
59.7
111
85.26
83.44
104
96.22
110
97.39
69.65
33.65
Cash Conversion Cycle
181
194
205
73.29
82.72
74.72
107
107
35.56
26.81
38.02
83.23
Working Capital Days
97.04
111
86.74
20.89
27.88
25.18
-14.06
6.82
-20.21
-7.69
-13.89
-5.77
ROCE %
3.39%
0.87%
1.91%
2.95%
5.39%
5.79%
-15.09%
8.26%
-14.8%
9.72%
41.41%
39.24%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Gujarat Terce Laboratories insights

63 extracted metrics + investor summaries across FY09–FY26.

Log in — free

Shareholding Pattern

Public54.37%Others5.61%Promot.40.03%As ofJun 2026

Documents

1
Concall - Jun 2026 Jun 2026
2
Concall - Nov 2025 Nov 2025
3
Concall - Aug 2025 Aug 2025
4
Concall - May 2025 May 2025
5
Concall - Feb 2025 Feb 2025

Frequently Asked Questions about Gujarat Terce Laboratories

What does Gujarat Terce Laboratories Ltd do?
Incorporated in 1985. Gujarat Terce Laboratories Ltd is engaged in development, manufacturing, marketing and distribution of medicines, healthcare products and branded generics
Where is Gujarat Terce Laboratories Ltd (524314) listed?
Gujarat Terce Laboratories Ltd trades as GUJARATTERCELABORATORIESLTD on the NSE and under code 524314 on the BSE.
Which sector does Gujarat Terce Laboratories Ltd belong to?
Gujarat Terce Laboratories Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Gujarat Terce Laboratories Ltd?
Gujarat Terce Laboratories Ltd has a market capitalisation of ₹32.76 Cr, which places it in the Small Cap band.
What is the PE ratio of Gujarat Terce Laboratories Ltd?
Gujarat Terce Laboratories Ltd trades at a PE ratio of 15.30, on earnings per share of ₹0, against a book value of ₹12.49 per share.
What is the 52-week high and low of Gujarat Terce Laboratories Ltd?
Over the last 52 weeks Gujarat Terce Laboratories Ltd has traded between ₹29 and ₹59.78.
What is the Return on Equity (ROE) of Gujarat Terce Laboratories Ltd?
Gujarat Terce Laboratories Ltd reported a return on equity of 22.63%. Its debt-to-equity ratio is 0.13.

Company Information

Incorporated in 1985. Gujarat Terce Laboratories Ltd is engaged in development, manufacturing, marketing and distribution of medicines, healthcare products and branded generics

Website gujaratterce.in
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524314.md for Gujarat Terce Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List